skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 87,170  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmj remove subject: Humans remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Gamma-glutamyl transpeptidase, triglycerides, and enzyme induction
Gamma-glutamyl transpeptidase, triglycerides, and enzyme induction
Material Type:
Article 		Add to My Research

Gamma-glutamyl transpeptidase, triglycerides, and enzyme induction

British Medical Journal, 1975-01, Vol.1 (5948), p.17-18 [Peer Reviewed Journal]

Copyright 1975 British Medical Journal ;Copyright BMJ Publishing Group LTD Jan 4, 1975 ;ISSN: 0007-1447 ;EISSN: 1468-5833 ;DOI: 10.1136/bmj.1.5948.17 ;PMID: 235344

Full text available

Citations Cited by
2
Calculating the sample size required for developing a clinical prediction model
Calculating the sample size required for developing a clinical prediction model
Material Type:
Article 		Add to My Research

Calculating the sample size required for developing a clinical prediction model

BMJ (Online), 2020-03, Vol.368, p.m441-m441 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m441 ;PMID: 32188600

Full text available

Citations Cited by
3
Covid-19: risk factors for severe disease and death
Covid-19: risk factors for severe disease and death
Material Type:
Article 		Add to My Research

Covid-19: risk factors for severe disease and death

BMJ (Online), 2020-03, Vol.368, p.m1198-m1198 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m1198 ;PMID: 32217618

Full text available

Citations Cited by
4
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
Material Type:
Article 		Add to My Research

Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies

BMJ (Online), 2020-03, Vol.368, p.m689-m689 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m689 ;PMID: 32213531

Full text available

Citations Cited by
5
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

BMJ (Online), 2022-03, Vol.376, p.e068632-e068632 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2021-068632 ;PMID: 35236664

Full text available

Citations Cited by
6
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
Material Type:
Article 		Add to My Research

A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

BMJ (Online), 2021-09, Vol.374, p.n2061-n2061 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n2061 ;PMID: 34593508

Full text available

Citations Cited by
7
Medical error—the third leading cause of death in the US
Medical error—the third leading cause of death in the US
Material Type:
Article 		Add to My Research

Medical error—the third leading cause of death in the US

BMJ (Online), 2016-05, Vol.353, p.i2139-i2139 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Copyright BMJ Publishing Group LTD May 3, 2016 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i2139 ;PMID: 27143499

Full text available

Citations Cited by
8
Self controlled case series methods: an alternative to standard epidemiological study designs
Self controlled case series methods: an alternative to standard epidemiological study designs
Material Type:
Article 		Add to My Research

Self controlled case series methods: an alternative to standard epidemiological study designs

BMJ (Online), 2016-09, Vol.354, p.i4515-i4515 [Peer Reviewed Journal]

ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i4515 ;PMID: 27618829

Full text available

Citations Cited by
9
Process evaluation of complex interventions: Medical Research Council guidance
Process evaluation of complex interventions: Medical Research Council guidance
Material Type:
Article 		Add to My Research

Process evaluation of complex interventions: Medical Research Council guidance

BMJ (Online), 2015-03, Vol.350 (mar19 6), p.h1258-h1258 [Peer Reviewed Journal]

Moore et al 2015 ;BMJ Publishing Group Ltd 2015 ;Copyright BMJ Publishing Group LTD Mar 19, 2015 ;Moore et al 2015 2015 Moore et al ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.h1258 ;PMID: 25791983

Full text available

Citations Cited by
10
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
Material Type:
Article 		Add to My Research

Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline

BMJ (Online), 2020-01, Vol.368, p.l6890-l6890 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.l6890 ;PMID: 31948937

Full text available

Citations Cited by
11
A living WHO guideline on drugs for covid-19
A living WHO guideline on drugs for covid-19
Material Type:
Article 		Add to My Research

A living WHO guideline on drugs for covid-19

BMJ (Online), 2020-09, Vol.370, p.m3379-m3379 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m3379 ;PMID: 32887691

Full text available

Citations Cited by
12
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction
Material Type:
Article 		Add to My Research

GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction

BMJ (Online), 2016-06, Vol.353, p.i2016-i2016 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Copyright BMJ Publishing Group LTD Jun 28, 2016 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i2016 ;PMID: 27353417

Full text available

Citations Cited by
13
Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration
Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration
Material Type:
Article 		Add to My Research

Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration

BMJ (Online), 2021-10, Vol.375, p.n2233-n2233 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n2233 ;PMID: 34702754

Full text available

Citations Cited by
14
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Material Type:
Article 		Add to My Research

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

BMJ (Online), 2022-03, Vol.376, p.e069761-e069761 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2021-069761 ;PMID: 35264324

Full text available

Citations Cited by
15
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Material Type:
Article 		Add to My Research

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

BMJ (Online), 2021-03, Vol.372, p.n579-n579 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n579 ;PMID: 33687922

Full text available

Citations Cited by
16
Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies
Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies
Material Type:
Article 		Add to My Research

Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies

BMJ (Online), 2016-06, Vol.353, p.i2716-i2716 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright BMJ Publishing Group LTD Jun 14, 2016 ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2016 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i2716 ;PMID: 27301975

Full text available

Citations Cited by
17
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
Material Type:
Article 		Add to My Research

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

BMJ (Online), 2021-03, Vol.372, p.n160-n160 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n160 ;PMID: 33781993

Full text available

Citations Cited by
18
Mortality due to cancer treatment delay: systematic review and meta-analysis
Mortality due to cancer treatment delay: systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Mortality due to cancer treatment delay: systematic review and meta-analysis

BMJ (Online), 2020-11, Vol.371, p.m4087-m4087 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m4087 ;PMID: 33148535

Full text available

Citations Cited by
19
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines
Material Type:
Article 		Add to My Research

GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines

BMJ (Online), 2016-06, Vol.353, p.i2089-i2089 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Copyright BMJ Publishing Group LTD Jun 30, 2016 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i2089 ;PMID: 27365494

Full text available

Citations Cited by
20
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Material Type:
Article 		Add to My Research

Adiposity and cancer at major anatomical sites: umbrella review of the literature

BMJ (Online), 2017-02, Vol.356, p.j477-j477 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2017 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.j477 ;PMID: 28246088

Full text available

Citations Cited by

Results 1 - 20 of 87,170  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1960  (6,853)
  2. 1960 To 1975  (13,899)
  3. 1976 To 1991  (22,548)
  4. 1992 To 2008  (24,379)
  5. After 2008  (19,492)
  6. More options open sub menu

Resource Type 

  1. Articles  (87,169)
  2. Reviews  (1)
  3. More options open sub menu

Subject 

  1. General & Internal Medicine  (87,164)
  2. Medicine, General & Internal  (87,164)
  3. Female  (23,913)
  4. Male  (17,008)
  5. Correspondence  (14,108)
  6. Letter  (13,432)
  7. Adult  (12,724)
  8. United Kingdom  (11,097)
  9. Middle Aged  (10,101)
  10. Old Medline  (9,611)
  11. Aged  (8,356)
  12. Child  (7,008)
  13. Letters  (6,582)
  14. Pregnancy  (6,379)
  15. News  (6,187)
  16. Adolescent  (5,915)
  17. Biological And Medical Sciences  (5,265)
  18. More options open sub menu

Language 

  1. Japanese  (2,455)
  2. Norwegian  (12)
  3. Russian  (6)
  4. French  (2)
  5. German  (2)
  6. Polish  (1)
  7. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait